PubRank

Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28649644)

Published in NPJ Breast Cancer on February 23, 2017

Authors

Xavier Pivot1, Gilles Romieu2, Pierre Fumoleau3, Maria Rios4, Hervé Bonnefoi5, Thomas Bachelot6, Patrick Soulié7, Christelle Jouannaud8, Hugues Bourgeois9, Thierry Petit10, Isabelle Tennevet11, David Assouline12, Marie-Christine Mathieu13, Jean-Philippe Jacquin14, Sandrine Lavau-Denes15, Ariane Darut-Jouve16, Jean-Marc Ferrero17, Carole Tarpin18, Christelle Lévy19, Valérie Delecroix20, Véronique Trillet-Lenoir21, Oana Cojocarasu22, Jérôme Meunier23, Jean-Yves Pierga24, Cécile Agostini25, Pierre Kerbrat26, Céline Faure-Mercier27, Hélène Blanché28, Mourad Sahbatou28, Anne Boland29, Delphine Bacq29, Céline Besse29, Fabien Calvo13, Alexia Renaud30, Jean-François Deleuze28,29, Iris Pauporté27, Gilles Thomas31, David G Cox30

Author Affiliations

1: Hôpital Jean-Minjoz, Centre Hospitalier Universitaire INSERM 1098, Boulevard Fleming, Besançon, 25030 France.
2: Oncologie Sénologie, ICM Institut Régional du Cancer, Montpellier, CEDEX 34298 France.
3: Georges-François Leclerc, 1 Rue du Professeur Marion, Dijon, 21000 France.
4: Département d'Oncologie Médicale, Institut de Cancérologie de Lorraine-Alexis Vautrin, 6, avenue de Bourgogne, VANDOEUVRE LES NANCY, CEDEX 54511 France.
5: Département d'Oncologie Médicale, Institut Bergonié, 229 Cours de l'Argonne, Bordeaux, 33000 France.
6: Département de Cancérologie Médicale, Centre Léon Bérard, 28 rue Laënnec, Lyon, CEDEX 08 France.
7: Institut de Cancérologie de l'Ouest, Service Oncologie Médicale, 2 rue Moll, Angers, CEDEX 09 49993 France.
8: Institut Jean Godinot, Service Oncologie Médicale, 1 rue du Général Koenig, Reims, CEDEX 51056 France.
9: Clinique Victor Hugo-Centre Jean Bernard, 18 rue Victor Hugo, Le Mans, CEDEX 2 72015 France.
10: Centre Paul Strauss, Service d'Oncologie Médicale, 3 rue de la Porte de l'Hôpital, Strasbourg, CEDEX 67065 France.
11: Centre Henri Becquerel, rue d'Amiens, Rouen, 76038 France.
12: Institut Daniel Hollard, Service Oncologie Médicale, 8 rue du Docteur Calmette, Grenoble, CEDEX 01 38028 France.
13: Institut Gustave Roussy, Comité de Pathologie mammaire, 39 rue Camille Desmoulins, Villejuif, CEDEX 94805 France.
14: Institut de Cancérologie Lucien Neuwirth, Service Oncologie Médicale, 108 bis avenue Albert Raimond, Saint Priest en Jarez, 42270 France.
15: Centre Hospitalier de Limoges, Service d'Oncologie Médicale, 2 avenue Martin Luther King, Limoges, CEDEX 87042 France.
16: Clinique Drévon, Centre d'oncologie et de radiothérapie du Parc, 18 cours du général de Gaulle, Dijon, 21000 France.
17: Département Oncologie Médicale, Centre Antoine Lacassagne, 33 avenue de Valombrose, Nice, CEDEX 02 06189 France.
18: Département d'Oncologie Médicale, Institut Paoli-Calmettes, 232 Boulevard de Sainte-Marguerite, Marseille, 13009 France.
19: Centre François Baclesse, 3 avenue du Général Harris, Caen, CEDEX 5 14076 France.
20: Centre Etienne Dolet, Pôle Mutualiste, Service Oncologie Médicale, 11 boulevard Georges Charpak, Saint Nazaire, 44606 France.
21: Centre Hospitalier Lyon Sud, Service d'Oncologie Médicale, 165 chemin du Grand Revoyet, Pierre-Benite cedex, 69495 France.
22: Centre Hospitalier Le Mans, Service d'Onco-Hématologie et Médecine interne, 194 avenue Rubillard, Le Mans, CEDEX 72037 France.
23: Centre Hospitalier Régional d'Orléans, Service d'Oncologie médicale, 1 rue Porte Madeleine, ORLEANS, CEDEX 1 45032 France.
24: Department of Medical Oncology, Institut Curie, 26 rue d'Ulm, Paris, CEDEX 05 75248 France.
25: Centre Hospitalier de Chambéry, Service Oncologie médicale, Place du Docteur François Chiron, Chambéry, 73000 France.
26: Centre Eugène Marquis, Service Oncologie médicale, Rue de la Bataille Flandres-Dunkerque, CS 44229, Rennes, CEDEX 35042 France.
27: Institut National du Cancer, Direction de la Recherche, 52 avenue Morizet, Boulogne-Billancourt, 92513 France.
28: Centre d'Etudes du Polymorphisme Humain, 27 rue Juliette Dodu, Paris, 75010 France.
29: Centre National du Génotypage, 2 rue Gaston Crémieux, CP 5721, Evry, CEDEX 91057 France.
30: Centre de Recherche en Cancérologie de Lyon, INSERM U1052-Centre Léon Bérard, 28 rue Laennec, Lyon, 69373 France.
31: Synergie Lyon Cancer, Centre Léon Bérard, 28 rue Laënnec, Lyon, CEDEX 08 France.

Articles cited by this ↗

Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23

International network of cancer genome projects. Nature (2010) 20.35

Gene-expression signatures in breast cancer. N Engl J Med (2009) 9.23

Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet (2013) 3.87

Trastuzumab in the treatment of breast cancer. N Engl J Med (2005) 3.86

Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature (2016) 3.05

Avoiding the high Bonferroni penalty in genome-wide association studies. Genet Epidemiol (2010) 2.79

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 2.72

6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial. Lancet Oncol (2013) 2.39

Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humans. Hum Mol Genet (2012) 1.77

A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk. Hum Mol Genet (2013) 1.52

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. Nat Genet (2016) 0.92

A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers. Nat Commun (2016) 0.88

Low prevalence of HER2 positivity amongst BRCA1 and BRCA2 mutation carriers and in primary BRCA screens. Breast Cancer Res Treat (2016) 0.78